CD44-targeted nanocarrier for cancer therapy
Cluster of differentiation 44 (CD44) is a cell surface glycoprotein overexpressed in varieties
of solid tumors including pancreatic, breast, ovary, brain, and lung cancers. It is a multi …
of solid tumors including pancreatic, breast, ovary, brain, and lung cancers. It is a multi …
Nanoparticle-based drug delivery systems in cancer: A focus on inflammatory pathways
It has become necessary to accept the clinical reality of therapeutic agents targeting the
cancer-associated immune system. In recent decades, several investigations have …
cancer-associated immune system. In recent decades, several investigations have …
Tumor-and mitochondria-targeted nanoparticles eradicate drug resistant lung cancer through mitochondrial pathway of apoptosis
H Wang, F Zhang, H Wen, W Shi, Q Huang… - Journal of …, 2020 - Springer
Chemotherapeutic drugs frequently encounter multidrug resistance. ATP from mitochondria
helps overexpression of drug efflux pumps to induce multidrug resistance, so mitochondrial …
helps overexpression of drug efflux pumps to induce multidrug resistance, so mitochondrial …
PEGylated polylactide (PLA) and poly (lactic-co-glycolic acid)(PLGA) copolymers for the design of drug delivery systems
Background PEGylated polylactide (PLA) and poly (lactic-co-glycolic acid)(PLGA)
copolymers are biodegradable polyesters, widely employed in the last decades for the …
copolymers are biodegradable polyesters, widely employed in the last decades for the …
Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment
Y Song, H Cai, T Yin, M Huo, P Ma… - International Journal of …, 2018 - Taylor & Francis
Background Lung cancer is the primary cause of cancer-related death worldwide. A redox-
sensitive nanocarrier system was developed for tumor-targeted drug delivery and sufficient …
sensitive nanocarrier system was developed for tumor-targeted drug delivery and sufficient …
Nanocomposites as biomolecules delivery agents in nanomedicine
M Bamburowicz-Klimkowska, M Poplawska… - Journal of …, 2019 - Springer
Nanoparticles (NPs) are atomic clusters of crystalline or amorphous structure that possess
unique physical and chemical properties associated with a size range of between 1 and 100 …
unique physical and chemical properties associated with a size range of between 1 and 100 …
[PDF][PDF] Drug targeting strategies based on charge dependent uptake of nanoparticles into cancer cells
M Saadat, F Zahednezhad… - … of Pharmacy & …, 2019 - frontierspartnerships.org
The aim of this review was to describe the preferred charged nano-particles (CNPs) for
targeted delivery in tumor cells. Zeta Potential (ZP), which represents the surface charge of …
targeted delivery in tumor cells. Zeta Potential (ZP), which represents the surface charge of …
Hyaluronic acid-based nanomaterials applied to cancer: where are we now?
V Machado, M Morais, R Medeiros - Pharmaceutics, 2022 - mdpi.com
Cancer cells normally develop the ability to rewire or reprogram themselves to become
resistant to treatments that were previously effective. Despite progress in understanding …
resistant to treatments that were previously effective. Despite progress in understanding …
[图书][B] Encyclopedia of Polymer Applications, 3 Volume Set
M Mishra - 2018 - taylorfrancis.com
Undoubtedly the applications of polymers are rapidly evolving. Technology is continually
changing and quickly advancing as polymers are needed to solve a variety of day-to-day …
changing and quickly advancing as polymers are needed to solve a variety of day-to-day …
New developments and clinical transition of hyaluronic acid-based nanotherapeutics for treatment of cancer: reversing multidrug resistance, tumour-specific …
MH Safdar, Z Hussain, MAS Abourehab… - Artificial Cells …, 2018 - Taylor & Francis
This review aims to overview and critically analyses recent developments in achieving
tumour-specific delivery of anticancer agents, maximizing anticancer efficacy, and mitigating …
tumour-specific delivery of anticancer agents, maximizing anticancer efficacy, and mitigating …